6.48
전일 마감가:
$6.75
열려 있는:
$6.71
하루 거래량:
1.36M
Relative Volume:
0.62
시가총액:
$2.38B
수익:
$9.47B
순이익/손실:
$-178.00M
주가수익비율:
-13.50
EPS:
-0.48
순현금흐름:
$1.01B
1주 성능:
-9.50%
1개월 성능:
-15.29%
6개월 성능:
-21.55%
1년 성능:
-38.93%
Bausch Health Companies Inc Stock (BHC) Company Profile
명칭
Bausch Health Companies Inc
전화
514-744-6792
주소
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
BHC을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
BHC
Bausch Health Companies Inc
|
6.48 | 2.38B | 9.47B | -178.00M | 1.01B | -0.48 |
![]()
ZTS
Zoetis Inc
|
163.11 | 73.07B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.05 | 47.43B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
HLN
Haleon Plc Adr
|
10.24 | 45.72B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.08 | 17.28B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
ITCI
Intra Cellular Therapies Inc
|
131.81 | 14.03B | 612.78M | -86.37M | -62.91M | -0.87 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-08-02 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
2024-07-10 | 개시 | Raymond James | Mkt Perform |
2023-09-20 | 업그레이드 | Jefferies | Hold → Buy |
2023-06-16 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
2022-07-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2022-07-29 | 다운그레이드 | Truist | Buy → Hold |
2022-07-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2022-06-13 | 재개 | JP Morgan | Overweight |
2021-03-24 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2021-02-17 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
2021-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2020-09-17 | 업그레이드 | BofA Securities | Underperform → Neutral |
2020-08-24 | 재확인 | H.C. Wainwright | Buy |
2020-06-17 | 재확인 | H.C. Wainwright | Buy |
2020-04-24 | 개시 | Citigroup | Buy |
2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2020-01-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
2020-01-22 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
2019-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
2019-12-02 | 개시 | Goldman | Neutral |
2019-10-25 | 개시 | Cowen | Outperform |
2019-09-12 | 개시 | Guggenheim | Buy |
2019-08-15 | 업그레이드 | TD Securities | Hold → Buy |
2019-07-19 | 개시 | Wolfe Research | Outperform |
2019-06-11 | 재개 | Barclays | Overweight |
2019-05-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
2019-03-20 | 개시 | SunTrust | Buy |
2019-01-02 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
2018-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2018-09-13 | 업그레이드 | Piper Jaffray | Underweight → Neutral |
모두보기
Bausch Health Companies Inc 주식(BHC)의 최신 뉴스
Bausch Health to Announce First Quarter Results on April 30 - Batesville Daily Guard
Bausch Health revenue by segment 2021-2024 - Statista
Bausch Health Upsizes Private Offering to $4.4 Billion - TipRanks
Bausch Health upsizes senior notes offering to $4.4 billion By Investing.com - Investing.com South Africa
Bausch Health upsizes senior notes offering to $4.4 billion - Investing.com India
Bausch Health Prices Upsized Private Offering of Senior Secured Notes - Marketscreener.com
Bausch Health Announces Pricing Of Upsized Private Offering Of Senior Secured Notes - Marketscreener.com
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes - ACCESS Newswire
Major Refinancing: Bausch Health Lands $7.9B Deal, Pledges Bausch + Lomb Stake - StockTitan
Shareholders in Bausch Health Companies (NYSE:BHC) are in the red if they invested three years ago - Yahoo Finance
Bausch Health announces debt refinancing plans By Investing.com - Investing.com South Africa
Bausch Health announces debt refinancing plans - Investing.com
Bausch Health Announces Conditional Redemption of Senior Notes - TipRanks
Bausch Health Brief: Announcing Conditional Redemption of Senior Notes -March 21, 2025 at 04:24 pm EDT - Marketscreener.com
Bausch Health's Massive $7.4B Debt Overhaul Extends Maturity to 2032 - StockTitan
After losing 25% in the past year, Bausch Health Companies Inc. (NYSE:BHC) institutional owners must be relieved by the recent gain - Simply Wall St
Bausch Health finance plan gets thumbs up at Raymond James - Cantech Letter
BHC Stock Price, News and Analysis - Cantech Letter
Optical Coherence Tomography Devices Market Future Business - openPR
Raymond James maintains Bausch Health stock Market Perform By Investing.com - Investing.com South Africa
Raymond James maintains Bausch Health stock Market Perform - Investing.com
Bausch Health seeks $3.8 billion in new credit facilities - Investing.com Australia
Bausch + Lomb credit rating upgraded to ’B’ at S&P, parent company outlook developing - Investing.com
Bausch Health seeks $3.8 billion in new credit facilities By Investing.com - Investing.com South Africa
Bausch Health Launches $3.8 Billion Credit Facilities Syndication - TipRanks
Bausch Health Launches Syndication Of New Senior Secured Credit Facilities Totaling At Least $3.8 Bln - Marketscreener.com
Bausch Health Launches $3.8 Billion Credit Facilities -March 19, 2025 at 12:15 pm EDT - Marketscreener.com
Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities - ACCESS Newswire
Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes - ACCESS Newswire
Intraocular Lens Market Research Methodologies Offers High - openPR
Bausch Health announces next steps in financining initiative - Yahoo Finance
Bausch Health Companies Announces Next Steps In Financing Initiative With J.P. Morgan - Marketscreener.com
Bausch Health seeks financing with J.P. Morgan aid By Investing.com - Investing.com South Africa
Bausch Health seeks financing with J.P. Morgan aid - Investing.com India
Bausch Health Brief: Says Has engaged J.P. Morgan in connection with Its previously announced financing objectives - Marketscreener.com
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan - Voice Of Alexandria
Bausch Health Taps JP Morgan to Lead Major Financial Restructuring Initiative - StockTitan
What is Zacks Research’s Forecast for BHC Q2 Earnings? - Defense World
Acne Market on Track for Major Expansion by 2032, According to DelveInsight | Clinuvel Pharma, Novan, Dermata Therapeutics, ioPharmX, Bausch Health Americas, Inc., Kintor Pharma, Sol-Gel Technologies - Barchart
Microkeratome Market Detailed In New Research Report 2025 | - openPR
Overt Hepatic Encephalopathy Treatment Market: Key - openPR
Bausch Health Companies Inc. (NYSE:BHC) Receives $7.42 Consensus PT from Analysts - Defense World
Cosmetic Surgery Market Forecast Report and Company - GlobeNewswire
Cosmetic Surgery Market Forecast Report and Company Analysis 2025-2033 Featuring AbbVie, Cutera, Sientra, Bausch Health, Johnson & Johnson, Apyx Medical, Hologic, Merz Pharma, Galderma, Cynosure - Yahoo Finance
Actinic Keratosis Market Is Booming Worldwide 2025-2032 | - openPR
Bausch Health projects $4.95B-$5.1B revenue for 2025 with focus on growth and innovation - MSN
Scar Treatment Market Projected To Witness Massive Growth, - openPR
SHAREHOLDER ALERT: Potential Recovery for Bausch Health Companies Inc. (BHC) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Bausch Health Companies Inc.(BHC) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Bausch Health Companies Inc (BHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):